Key result
Rocuronium at doses of 0.45, 0.6, or /kg produced rapid-onset neuromuscular blockade with median time to T3 reappearance ranging from 21 to 114 minutes across age and dose groups.
Why the study?
Does rocuronium at different doses affect the time to reappearance of the third twitch in pediatric surgical patients?
RCT (n=207)
assessor-blinded
randomized
Yes
Does rocuronium at different doses affect the time to reappearance of the third twitch in pediatric surgical patients?
Rocuronium at doses of 0.45, 0.6, or 1.0 mg/kg produces rapid-onset neuromuscular blockade with dose-dependent duration in pediatric patients.
Answers are grounded in this paper and cite their sources.
Enables dose selection for rapid pediatric blockade; extends RCT evidence on age- and dose-dependent recovery.
Background: We evaluated the time course of neuromuscular blockade (NMB) of three intubating doses of rocuronium in pediatric patients. Methods: This multicenter, randomized, assessor-blinded study included surgical patients aged 0 to 17 years. Anesthesia was induced with sevoflurane, continued until intubation, and maintained with isoflurane. Neuromuscular function was monitored by acceleromyography. Patients received a rocuronium dose of 0.45, 0.6 or 1.0 mg/kg, and intubation was attempted 60 sec later. Primary outcome variable was time from end of rocuronium administration to reappearance of the third twitch (T3). Time to onset of peak NMB was assessed. Safety assessments included monitoring adverse events. Results: A total of 207 patients were enrolled and randomized. Median times from rocuronium administration to NMB onset were <1.2 minutes in all age groups for each dose in the per-protocol population (n=175). Median time from rocuronium administration to reappearance of T3 ranged from 21 to 114 minutes overall, and was longer in the higher dose groups across age groups, and longer in neonates and infants compared with other age groups. There were no adverse events considered related to rocuronium. Conclusions: Rocuronium at intubating doses of 0.45, 0.6, or 1.0 mg/kg is effective in producing rapid-onset neuromuscular blockade with an intermediate duration of action in pediatric patients during sevoflurane induction/ isoflurane maintenance anesthesia. Longest duration of blockade occurred with the highest dose within all age groups, and in neonates and infants compared with other age groups.
No takes yet. Share an insight, caveat, or question.
Tirotta et al. (2012) conducted an RCT in surgical patients requiring intubation (n=207). Rocuronium was evaluated on time from end of rocuronium administration to reappearance of the third twitch (T3). Rocuronium at doses of 0.45, 0.6, or /kg produced rapid-onset neuromuscular blockade with median time to T3 reappearance ranging from 21 to 114 minutes across age and dose groups.
Synapse has enriched 10 related papers. Consider them for comparative context: